Over the past several years, genetics, genomics, imaging, and targeted therapies have reshaped how advanced or metastatic prostate cancer is diagnosed and treated. But how can these tools be applied effectively in clinical practice to improve patient outcomes?

Hearing from our speakers, this webinar will explore how clinicians can integrate genetic and genomic insights, leverage recently approved therapies, and apply advanced imaging techniques such as PSMA-PET to guide treatment decisions. Don’t miss this opportunity to learn how cutting-edge science is transforming care for patients with advanced prostate cancer.